>FASTA_32

Colossal rhinos; Origin by Nucleus; Manhattan Genomics; Evvy; Contraline; Semiglutide patents; Valthos biodefense; Plasmidsaurus; Claude Life Science; Adaptyx Bioscience; InnCoCells; Cultured fruit...

>FASTA is constantly evolving. You can now read 10 weekly news of non-trad biotech faster. In honor to paid subscribers, there’s 10 extra bits with explainer paragraphs | Follow on Twitter, LinkedIn and YouTube for more content.

The spookiest biotech in a nutshell

1. 🦏 The Biorescue Consortium is partnering with Colossal Biosciences to save the Northern White Rhino using IVF and genetic engineering.

2. 🔬 Nucleus Genomics launched Origin, a set of open-weighted models for polygenic risk assessment of nine different diseases in IVF embryos.

3. 🧬 Preventive raised $30M from private investors to assess the safety of human embryo gene editing as a Public Benefit Corporation.

4. 👼 Manhattan Genomics is a New York-based startup pursuing human embryo editing for medical purposes.

5. 🎙️ Biofounders interview with Alexander Titus: Biotech from the Pentagon to Silicon Valley, storytelling, and frameworks for progress in our industry.

6. 🦠 Former Palantir Lifesci director launches Valthos, a biodefense software startup, backed by $30M from OpenAI, Founders Fund and Lux Capital.

7. 🤖 Claude will now connect to Benchling, Biorender, PubMed, 10X Genomics and other apps, and be able to perform quality control of genomic data.

8. 🖥️ Benchling is giving scientists direct access to NVIDIA’s GPU-optimized protein folding models.

9. 🦖 Plasmidsaurus launched a new RNA-Seq service for Illumina short reads.

10. 🧛‍♂️ Bryan Johnson raised $60M to bring his longevity protocol to the mainstream through Blueprint.

Extra Biopunk: Adaptyx biosensors, Evvy vaginal microbiome tests, Contraline male contraceptives, Chinese animal models, expiring GLP-1 patents, protein supplement reports, €8M for cell cultured cosmetics, lab-grown fruit research, bioelectric pumpkins…